WHO says more data needed on AstraZeneca dose – ET HealthWorld

Oxford and AstraZeneca reported on Monday that their vaccine appeared 62% efficient in individuals who acquired two doses and 90% efficient when volunteers got a half dose adopted by a full dose. They later acknowledged a producing difficulty had resulted in a half dose mistakenly being administered as the primary dose to some members.

Dr Soumya Swaminathan, WHO’s chief scientist, stated at a Friday media briefing that “the numbers are still too small to really come to any definitive conclusions”. In the examine, 2,741 folks bought a half dose adopted by a full dose whereas 8,895 folks bought two full doses. None of the folks within the half-dose routine had been over age 55. “It’s hard to compare these two groups,” she stated. She stated the company had heard AstraZeneca wish to conduct a full examine testing the half dose adopted by a full-dose routine, noting that the opposite ongoing analysis evaluating the vaccine makes use of two full doses. ap